Lindville Bio is an advanced therapies consultancy service specializing in the development and manufacture of Pluripotent Stem Cells (iPSC/hESC) therapies.
We are uniquely focused on the evolving science and market of iPSC/hESC therapies.
iPSC/hESC therapy translational journey requires expertise spanning multiple professional silos. Beginning with the patient and final medical product in mind, our approach is to adopt a holistic vision for translation to develop the most efficient and cost-effective route to clinical impact.
Our mission is to enable large scale clinical application of the new generation of iPSC/hESC therapies by helping our clients to tackle current and potential challenges to their development and manufacture.
We are a focused, knowledgeable, and globally well-networked team. We work closely with our clients to understand their needs and provide customized solutions. If we do not have the answers ourselves, we know who will.
London, UK
Philadelphia, USA
Philadelphia, USA
Munich, Germany
Munich, Germany
Munich, Germany
Munich, Germany
Estoril, Portugal
Estoril, Portugal
London, UK
London, UK
London, UK
London, UK
Stevenage, UK
Stevenage, UK
Munich, Germany